NewGenIvf Group Ltd (NIVF) FinancialsNIVFNewGenIvf Group Ltd

Evaluating the bottom line, NewGenIvf Group Ltd maintains a gross margin of 36.79%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -349.13%, while the net margin is -541.73%. These profitability ratios, combined with a Return on Equity (ROE) of 77.23%, provide a clear picture of how effectively NIVF converts its operational activities into shareholder value.

In the context of the broader market, NIVF competes directly with industry leaders such as MNDR and EDVA. With a market capitalization of $4.45M, it holds a leading position in the sector. When comparing efficiency, NIVF's gross margin of 36.79% stands against MNDR's 16.94% and EDVA's 43.75%. Such benchmarking helps identify whether NewGenIvf Group Ltd is trading at a premium or discount relative to its financial performance.

NIVF's financial performance shows significant volatility, with a gross margin fluctuating from 0% to 42.33% over recent quarters. The company reported a net income of -7,668,922 USD in Q4 2025, highlighting ongoing financial struggles.